6
H index
4
i10 index
160
Citations
Johann Matthias Graf von der Schulenburg : Citation Profile
Leibniz Universität Hannover | RESEARCH PRODUCTION: 40 Articles 3 Papers EDITOR: RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
36 years (1987 - 2023). Relations with other researchers
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Johann Matthias Graf von der Schulenburg. | Is cited by:
| Cites to:
|
Main data
Where Johann Matthias Graf von der Schulenburg has published?
| Journals with more than one article published | # docs |
|---|---|
| The European Journal of Health Economics | 12 |
| Health Economics Review | 10 |
| The Geneva Papers on Risk and Insurance - Issues and Practice | 5 |
| The Geneva Risk and Insurance Review | 3 |
| Health Policy | 3 |
Recent works citing Johann Matthias Graf von der Schulenburg (2025 and 2024)
| Year | Title of citing document |
|---|---|
| 2024 | Economic Incentives to Develop and to Use Diagnostic Tests a Literature Review. (2024). Bardey, David ; Zaporozhets, Vera ; de Donder, Philippe. In: Documentos CEDE. RePEc:col:000089:021024. Full description at Econpapers || Download paper |
| 2024 | The modernisation of newborn screening as a pan-European challenge – An international delphi study. (2024). Blankart, Carl ; Chalandon, Anne-Sophie ; Granados, Alicia ; Clemens, Andreas ; Gumus, Gulcin ; Nam, Julian ; Gillner, Sandra ; Iskrov, Georgi ; Gross, Edith ; Stefanov, Rumen ; Raycheva, Ralitsa. In: Health Policy. RePEc:eee:hepoli:v:149:y:2024:i:c:s0168851024001726. Full description at Econpapers || Download paper |
| 2025 | Signaling vs. agency theory: What drives dividends of promoter-owned firms during a crisis?. (2025). Chaudhry, Neeru ; Kashiramka, Smita ; Gosain, Neha. In: Research in International Business and Finance. RePEc:eee:riibaf:v:73:y:2025:i:pa:s0275531924003830. Full description at Econpapers || Download paper |
| 2025 | A new SF-6Dv2 value set based on a hybrid model using SG, cTTO, and DCE data. (2025). Poder, Thomas G ; Ameri, Hosein. In: Social Science & Medicine. RePEc:eee:socmed:v:366:y:2025:i:c:s0277953624010864. Full description at Econpapers || Download paper |
| 2025 | Overcoming the “valleys of death” in advanced therapies: The role of finance. (2025). Cosma, Simona ; Pennetta, Daniela ; Rimo, Giuseppe. In: Social Science & Medicine. RePEc:eee:socmed:v:366:y:2025:i:c:s0277953624010931. Full description at Econpapers || Download paper |
| 2024 | Socioeconomic per-case costs of stroke, myocardial infarction, and preterm birth attributable to air pollution in Sweden. (2024). Kriit, Hedi Katre ; Sommar, Johan Nilsson ; Strm, Stefan. In: PLOS ONE. RePEc:plo:pone00:0290766. Full description at Econpapers || Download paper |
| 2024 | Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation. (2024). Blankart, Katharina ; Vandoros, Sotiris. In: PLOS ONE. RePEc:plo:pone00:0301716. Full description at Econpapers || Download paper |
| 2024 | A cost-of-illness study of Behçet syndrome in Italy. (2024). Marinello, Diana ; Palla, Ilaria ; Lorenzoni, Valentina ; Mosca, Marta ; Turchetti, Giuseppe ; Talarico, Rosaria. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:3:d:10.1007_s10198-023-01593-8. Full description at Econpapers || Download paper |
| 2024 | Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease. (2024). Stargardt, Tom ; Bokemeyer, Bernd ; Steiner, Isa Maria. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:3:d:10.1007_s10198-023-01603-9. Full description at Econpapers || Download paper |
| 2024 | Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study. (2024). Klimek, Ludger ; Pfaar, Oliver ; Neusser, Silke ; Valbert, Frederik ; Neumann, Anja ; Wobbe-Ribinski, Stefanie ; Hillerich, Vivienne ; Wasem, Jrgen ; Riederer, Cordula ; Biermann-Stallwitz, Janine ; Hamelmann, Eckard ; Werfel, Thomas ; Sperl, Annette. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:4:d:10.1007_s10198-023-01598-3. Full description at Econpapers || Download paper |
| 2025 | Economic Incentives to Develop and to Use Diagnostic Tests - A Literature Review. (2024). De Donder, Philippe ; Bardey, David ; Zaporozhets, Vera. In: TSE Working Papers. RePEc:tse:wpaper:129120. Full description at Econpapers || Download paper |
Johann Matthias Graf von der Schulenburg is editor of
| Journal | |
|---|---|
| Health Economics Review |
Johann Matthias Graf von der Schulenburg has edited the books:
| Year | Title | Type | Cited |
|---|
Works by Johann Matthias Graf von der Schulenburg:
| Year | Title | Type | Cited |
|---|---|---|---|
| 1987 | Voting on Social Security: The Family as Decision‐Making Unit In: Kyklos. [Full Text][Citation analysis] | article | 7 |
| 2014 | Entwicklung der Leistungsempfängerzahlen in der Gesetzlichen Pflegeversicherung - Zum Einfluss unterschiedlicher Morbiditätsannahmen auf die Entwicklung der sozialrechtlich anerkannten Pflegebedürftigkeit in Deutschland In: Schmollers Jahrbuch : Journal of Applied Social Science Studies / Zeitschrift für Wirtschafts- und Sozialwissenschaften. [Full Text][Citation analysis] | article | 0 |
| 2012 | Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study In: Health Policy. [Full Text][Citation analysis] | article | 6 |
| 2022 | Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments In: Health Policy. [Full Text][Citation analysis] | article | 1 |
| 2002 | Diffusion of innovations: treatment of Alzheimers disease in Germany In: Health Policy. [Full Text][Citation analysis] | article | 2 |
| 2015 | Cost of poor adherence to anti-hypertensive therapy in five European countries In: Post-Print. [Citation analysis] | paper | 3 |
| 2014 | Grundlagen und Methoden von GKV-Routinedatenstudien In: Hannover Economic Papers (HEP). [Full Text][Citation analysis] | paper | 3 |
| 2007 | Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany? In: Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik). [Full Text][Citation analysis] | article | 0 |
| 1991 | Reliability of Risk Management: Market Insurance, Self-Insurance and Self-Protection Reconsidered In: The Geneva Risk and Insurance Review. [Full Text][Citation analysis] | article | 19 |
| 2009 | Reinsurance Brokers and Advice Quality: Is There a Need for Regulation? In: The Geneva Risk and Insurance Review. [Full Text][Citation analysis] | article | 2 |
| 2012 | Corporate Management of Highly Dynamic Risks: Evidence from the Demand for Terrorism Insurance in Germany In: The Geneva Risk and Insurance Review. [Full Text][Citation analysis] | article | 3 |
| 2010 | On the Impact of the Financial Crisis on the Dividend Policy of the European Insurance Industry In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] | article | 4 |
| 2010 | Impact of the Introduction of the Social Long-Term Care Insurance in Germany on Financial Security Assessment in Case of Long-Term Care Need* In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] | article | 8 |
| 2017 | An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] | article | 0 |
| 2019 | Correction to: An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies.(2019) In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | article | |
| 2020 | Affirmative and silent cyber coverage in traditional insurance policies: Qualitative content analysis of selected insurance products from the German insurance market In: The Geneva Papers on Risk and Insurance - Issues and Practice. [Full Text][Citation analysis] | article | 1 |
| 2013 | Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe In: CEIS Research Paper. [Full Text][Citation analysis] | paper | 0 |
| 2016 | Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2010 | Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2010 | EJHE has an official impact factor of 1.337 In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2011 | Letter from the editors In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2015 | Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2016 | Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 16 |
| 2020 | HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2021 | COVID-19: not the time for health economists? A plea for more proactive health economic involvement In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2002 | Commentary In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2005 | Validating the EQ-5D with time trade off for the German population In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 20 |
| 2005 | German health care system in transition In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 4 |
| 2005 | Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2007 | Editor’s note In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2011 | Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers In: Health Economics Review. [Full Text][Citation analysis] | article | 6 |
| 2011 | Greetings from the Editors In: Health Economics Review. [Full Text][Citation analysis] | article | 0 |
| 2011 | Promoting vaccinations - an analysis of measures taken by German statutory health insurers In: Health Economics Review. [Full Text][Citation analysis] | article | 0 |
| 2012 | Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany In: Health Economics Review. [Full Text][Citation analysis] | article | 4 |
| 2013 | Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system In: Health Economics Review. [Full Text][Citation analysis] | article | 0 |
| 2015 | Regional differences in health care of patients with inflammatory bowel disease in Germany In: Health Economics Review. [Full Text][Citation analysis] | article | 1 |
| 2015 | Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis - In: Health Economics Review. [Full Text][Citation analysis] | article | 1 |
| 2016 | Benefit assessment in Germany: implications for price discounts In: Health Economics Review. [Full Text][Citation analysis] | article | 3 |
| 2016 | Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks In: Health Economics Review. [Full Text][Citation analysis] | article | 3 |
| 2018 | “Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations In: Health Economics Review. [Full Text][Citation analysis] | article | 1 |
| 2018 | German Value Set for the EQ-5D-5L In: PharmacoEconomics. [Full Text][Citation analysis] | article | 22 |
| 1993 | Bonus options in health insurance by Peter Zweifel. Awer Academic Publishers, Dordrecht, 1992. No. of ges: xii + 141. ISBN 0‐7923‐1722‐X In: Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2023 | Digital Transformation in Back-Offices of German Insurance Companies In: International Journal of Innovation and Technology Management (IJITM). [Full Text][Citation analysis] | article | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated December, 22 2025. Contact: CitEc Team